These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 15492570)
1. Lymphedema after complete axillary node dissection for melanoma: assessment using a new, objective definition. Starritt EC; Joseph D; McKinnon JG; Lo SK; de Wilt JH; Thompson JF Ann Surg; 2004 Nov; 240(5):866-74. PubMed ID: 15492570 [TBL] [Abstract][Full Text] [Related]
2. Defining lower limb lymphedema after inguinal or ilio-inguinal dissection in patients with melanoma using classification and regression tree analysis. Spillane AJ; Saw RP; Tucker M; Byth K; Thompson JF Ann Surg; 2008 Aug; 248(2):286-93. PubMed ID: 18650640 [TBL] [Abstract][Full Text] [Related]
3. Predictors of lymphedema in patients with breast cancer undergoing axillary lymph node dissection in Hong Kong. Mak SS; Yeo W; Lee YM; Mo KF; Tse KY; Tse SM; Ho FP; Kwan WH Nurs Res; 2008; 57(6):416-25. PubMed ID: 19018216 [TBL] [Abstract][Full Text] [Related]
4. Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish Breast Cancer Cooperative Group. Husted Madsen A; Haugaard K; Soerensen J; Bokmand S; Friis E; Holtveg H; Peter Garne J; Horby J; Christiansen P Breast; 2008 Apr; 17(2):138-47. PubMed ID: 17928226 [TBL] [Abstract][Full Text] [Related]
5. Volume and Tissue Composition Changes Measured with Dual-Energy X-Ray Absorptiometry in Melanoma-Related Limb Lymphedema. Gjorup CA; Hendel HW; Zerahn B; Dahlstroem K; Drzewiecki KT; Klausen TW; Hölmich LR Lymphat Res Biol; 2017 Sep; 15(3):274-283. PubMed ID: 28885862 [TBL] [Abstract][Full Text] [Related]
6. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: patient perceptions and precautionary behaviors. McLaughlin SA; Wright MJ; Morris KT; Sampson MR; Brockway JP; Hurley KE; Riedel ER; Van Zee KJ J Clin Oncol; 2008 Nov; 26(32):5220-6. PubMed ID: 18838708 [TBL] [Abstract][Full Text] [Related]
7. Comparative morbidity of axillary lymph node dissection and the sentinel lymph node technique: implications for patients with breast cancer. Silberman AW; McVay C; Cohen JS; Altura JF; Brackert S; Sarna GP; Palmer D; Ko A; Memsic L Ann Surg; 2004 Jul; 240(1):1-6. PubMed ID: 15213610 [TBL] [Abstract][Full Text] [Related]
8. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements. McLaughlin SA; Wright MJ; Morris KT; Giron GL; Sampson MR; Brockway JP; Hurley KE; Riedel ER; Van Zee KJ J Clin Oncol; 2008 Nov; 26(32):5213-9. PubMed ID: 18838709 [TBL] [Abstract][Full Text] [Related]
9. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial]. Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111 [TBL] [Abstract][Full Text] [Related]
10. Axillary reverse lymphatic mapping reduces patient perceived incidence of lymphedema after axillary dissection in breast cancer. Pasko JL; Garreau J; Carl A; Ansteth M; Glissmeyer M; Johnson N Am J Surg; 2015 May; 209(5):890-5. PubMed ID: 25796096 [TBL] [Abstract][Full Text] [Related]
11. Lymphedema following axillary lymph node dissection for breast cancer. Sakorafas GH; Peros G; Cataliotti L; Vlastos G Surg Oncol; 2006 Nov; 15(3):153-65. PubMed ID: 17187979 [TBL] [Abstract][Full Text] [Related]
12. The incidence and risk factors for occurrence of arm lymphedema after treatment of breast cancer. Rebegea L; Firescu D; Dumitru M; Anghel R Chirurgia (Bucur); 2015; 110(1):33-7. PubMed ID: 25800313 [TBL] [Abstract][Full Text] [Related]
13. Obesity is a risk factor for developing postoperative lymphedema in breast cancer patients. Helyer LK; Varnic M; Le LW; Leong W; McCready D Breast J; 2010; 16(1):48-54. PubMed ID: 19889169 [TBL] [Abstract][Full Text] [Related]
14. Morbidity and Outcomes Following Axillary Lymphadenectomy for Melanoma: Weighing the Risk of Surgery in the Era of MSLT-II. Postlewait LM; Farley CR; Seamens AM; Le N; Rizzo M; Russell MC; Lowe MC; Delman KA Ann Surg Oncol; 2018 Feb; 25(2):465-470. PubMed ID: 29159743 [TBL] [Abstract][Full Text] [Related]
15. Lymphedema after treatment of breast cancer. Ozaslan C; Kuru B Am J Surg; 2004 Jan; 187(1):69-72. PubMed ID: 14706589 [TBL] [Abstract][Full Text] [Related]
16. Validity for the simplified water displacement instrument to measure arm lymphedema as a result of breast cancer surgery. Sagen A; Kåresen R; Skaane P; Risberg MA Arch Phys Med Rehabil; 2009 May; 90(5):803-9. PubMed ID: 19406300 [TBL] [Abstract][Full Text] [Related]
17. The changing role of axillary treatment in breast cancer: Who will remain at risk for developing arm morbidity in the future? Lopez Penha TR; van Roozendaal LM; Smidt ML; Boersma LJ; von Meyenfeldt MF; Voogd AC; Heuts EM Breast; 2015 Oct; 24(5):543-7. PubMed ID: 26051795 [TBL] [Abstract][Full Text] [Related]
18. Blue dye injection in the arm in order to conserve the lymphatic drainage of the arm in breast cancer patients requiring an axillary dissection. Nos C; Lesieur B; Clough KB; Lecuru F Ann Surg Oncol; 2007 Sep; 14(9):2490-6. PubMed ID: 17549570 [TBL] [Abstract][Full Text] [Related]
19. Agreement Between Optoelectronic Volumetry and Circumferential Girth Measurements to Diagnose Lymphedema in Patients Submitted to Axillary Radical Lymphadenectomy for Treatment of Cutaneous Melanoma. Campanholi LL; Baiocchi JMT; Batista BN; Bergmann A; Fregnani JHTG; Duprat Neto JP Lymphat Res Biol; 2021 Dec; 19(6):568-572. PubMed ID: 33555979 [No Abstract] [Full Text] [Related]
20. Reliability and validity of arm volume measurements for assessment of lymphedema. Taylor R; Jayasinghe UW; Koelmeyer L; Ung O; Boyages J Phys Ther; 2006 Feb; 86(2):205-14. PubMed ID: 16445334 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]